Navigation Links
Tension Building Up in FDA Over Drug Approvals

The US Food and Drug Administration, caught on the wrong foot again in just two years over the safety of the drugs it approves, is facing congressional investigations.

First it was Vioxx, the painkiller, then some antidepressants and most recently Avandia, the diabetes pill.

Concerns over that drug and others have led Republicans and Democrats in the House and the Senate to call for investigations.

The hearing next week may highlight the growing internal dissension between officials who approve drugs and those who track the safety of drugs after they have been approval. Tension between the groups has long been common, but in recent months it has erupted into sniping.

It all came into the open at an advisory committee hearing last month on whether to approve a new arthritis drug.

On one side was Dr. David Graham, author of an internal report that found that Avandia substantially increased the risks of heart attack, findings similar to the medical journals report.

On the other, Dr. Robert J. Meyer, an office director in the drug review division, and his boss, Dr. John Jenkins, were in a group deciding against warning about the potential risks.

There was little chance that the advisory committee or the drug agency would approve the arthritis drug, Arcoxia, at the hearing.

Behind the scenes, agency officials were battling over Avandia. Dr. Graham told the committee that top agency officials had demanded an unreasonable level of certainty about a drugs risks before agreeing to warn the public.

They assume its safe, Dr. Graham said of the top officials analyses of safety data. Which is just looking at things all the way wrong.

Dr. Jenkins said Dr. Grahams characterization of how we look at safety data is simply false.

We make our best informed judgment about what the regulatory action should be, Dr. Jenkins added.

The fact remains tho ugh even during Avandias original trials, overseen by GlaxoSmithKline, the drugs maker, patients taking the drug had more than twice the rate of ischemic heart disease as recipients of placebos.

The medical reviewer for the F.D.A. expressed concerns, but in a further analysis decided that it was less of a problem.

Congressional investigators said the safety group recommended months ago that the drug agency put its severest warning on Avandia. The review group, which holds sway, has not done so.

Senator Charles E. Grassley, Republican of Iowa, and others on Capitol Hill, say the rift between the approval office and the safety office means that the two must separate and that the safety group must have more power. Mr. Grassley proposed such a split in an amendment this month; it failed by one vote.

Top House staff members said the Avandia case had breathed new life into Mr. Grassleys proposal, because the House will soon debate changing the drug agency.

When Dr. Andrew C. von Eschenbach took over the FDA in 2005, he promised improvements, and agency officials said they would no longer be caught flatfooted on drug safety.

Now on the defensive, Dr. von Eschenbach said the agency had done its best in regard to Avandia. It intended to warn patients rapidly when it received information that a drug might be unsafe.

At the same time, he said, the agency had to find a way to ensure that patients did not overreact to uncertain safety problems.


'"/>




Related medicine news :

1. Acupuncture May Be An Effective Treatment Against Tension-Headaches
2. Children With Facial Anomalies Are Affected By Parental Tensions
3. Influence Of Heart Rate On Myocardial Oxygen Tension
4. Tension between MP And the Cancer Council Head Regarding Screening Test for Male Cancer
5. Milk Not So Good In Building Bones
6. Experts Building Bird Flu Warning System
7. Metamorphosis of U.S. Hospital Buildings
8. RMIT Business School Building Declared Safe
9. Researchers On The Path To Building Bone
10. Muscle-Building Exercise Improves Response to Flu Shot
11. Treat Childhood Trauma by Building on Parental Memories of Loving Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology: